Remarkably, this compound has the capability to prevent VEGF-mediated tumor angiogenesis induced by the CXCR4/CXCL12 axis in breast tumor xenografts [124] and exerts anti-metastatic activity in breast cancer in cultured cells and animal models [125,126,127]. Here, CXCR4 is linked to breast neoplasm.